Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
3192 |
|
| Actual shortage: | 257 (8%) | |
| Anticipated shortage: | 1 (0%) | |
| Avoided shortage: | 10 (0%) | |
| Resolved: | 2924 (92%) | |
Discontinuation Reports |
435 |
|
| To be discontinued: | 2 (0%) | |
| Discontinued: | 410 (94%) | |
| Reversed: | 23 (5%) | |
Late reports |
482 (13%) |
|
Overdue reports |
11 (4%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-FENTANYL | 100MCG | PATCH | Resolved | 2022-10-28 | 2022-12-02 | 173025 |
| TEVA-FENTANYL | 12MCG | PATCH | Resolved | 2023-01-12 | 2023-06-09 | 180909 |
| TEVA-FENTANYL | 50MCG | PATCH | Resolved | 2023-08-17 | 2023-10-04 | 202265 |
| TEVA-FENTANYL | 100MCG | PATCH | Resolved | 2024-01-25 | 2024-05-09 | 217223 |
| TEVA-FENTANYL | 25MCG | PATCH | Resolved | 2024-02-01 | 2024-05-30 | 218132 |
| TEVA-FENTANYL | 25MCG | PATCH | Resolved | 2024-02-01 | 2024-02-01 | 218134 |
| TEVA-FENTANYL | 50MCG | PATCH | Resolved | 2024-02-01 | 2024-05-30 | 218137 |
| TEVA-FENTANYL | 50MCG | PATCH | Resolved | 2024-06-20 | 2024-10-15 | 230964 |
| TEVA-FENTANYL | 75MCG | PATCH | Resolved | 2024-08-08 | 2024-11-21 | 234885 |
| TEVA-FENTANYL | 12MCG | PATCH | Resolved | 2025-01-15 | 2025-05-09 | 247779 |
| TEVA-FENTANYL | 50MCG | PATCH | Resolved | 2025-01-15 | 2025-05-15 | 247782 |
| TEVA-FENTANYL | 75MCG | PATCH | Resolved | 2025-01-15 | 2025-05-15 | 247785 |
| TEVA-FINASTERIDE | 5MG | TABLET | Resolved | 2017-08-21 | 2017-10-10 | 19944 |
| TEVA-FINASTERIDE | 5MG | TABLET | Resolved | 2020-05-01 | 2020-05-29 | 113785 |
| TEVA-FINASTERIDE | 5MG | TABLET | Resolved | 2021-09-30 | 2021-10-07 | 146459 |
| TEVA-FINASTERIDE | 5MG | TABLET | Resolved | 2023-02-09 | 2023-04-28 | 184210 |
| TEVA-FINASTERIDE | 5MG | TABLET | Actual shortage | 2025-11-20 | 2025-12-11 | 272307 |
| TEVA-FINGOLIMOD | 0.5MG | CAPSULE | Resolved | 2021-09-23 | 2021-11-25 | 146128 |
| TEVA-FINGOLIMOD | 0.5MG | CAPSULE | Resolved | 2021-12-02 | 2022-05-05 | 150406 |
| TEVA-FINGOLIMOD | 0.5MG | CAPSULE | Resolved | 2023-07-12 | 2025-03-20 | 198394 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-PREGABALIN | 75MG | CAPSULE | Discontinued | 2020-07-10 | 2020-07-10 | 120033 |
| TEVA-PREGABALIN | 225MG | CAPSULE | Discontinued | 2025-05-28 | 2025-05-28 | 258622 |
| TEVA-PREGABALIN | 150MG | CAPSULE | Discontinued | 2025-05-28 | 2025-05-28 | 258627 |
| TEVA-PREGABALIN | 25MG | CAPSULE | Discontinued | 2025-05-28 | 2025-05-28 | 258631 |
| TEVA-PREGABALIN | 300MG | CAPSULE | Discontinued | 2025-05-28 | 2025-05-28 | 258756 |
| TEVA-PROCTOSONE | 1% 1% 0.5% 0.5% | OINTMENT | Discontinued | 2025-04-25 | 2025-04-25 | 255840 |
| TEVA-PROFEN | 600MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258499 |
| TEVA-PROGESTERONE | 100MG | CAPSULE | Reversed | 2025-05-28 | 2025-06-20 | 258574 |
| TEVA-QUETIAPINE | 100MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64846 |
| TEVA-QUETIAPINE | 25MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64849 |
| TEVA-QUETIAPINE | 100MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 65036 |
| TEVA-QUETIAPINE | 200MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 65039 |
| TEVA-QUETIAPINE | 25MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 65044 |
| TEVA-QUETIAPINE | 300MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 65047 |
| TEVA-QUININE | 300MG | CAPSULE | Discontinued | 2020-01-24 | 2020-01-24 | 104294 |
| TEVA-QUININE | 200MG | CAPSULE | Discontinued | 2020-10-08 | 2020-10-09 | 125976 |
| TEVA-RABEPRAZOLE EC | 20MG | TABLET (DELAYED-RELEASE) | Discontinued | 2020-07-10 | 2020-07-10 | 120015 |
| TEVA-RABEPRAZOLE EC | 10MG | TABLET (DELAYED-RELEASE) | Discontinued | 2020-07-10 | 2020-07-10 | 120018 |
| TEVA-RANITIDINE | Discontinued | 2020-02-13 | 2020-02-13 | 106136 | ||
| TEVA-RANITIDINE | Discontinued | 2020-02-13 | 2020-02-13 | 106139 |